PortfoliosLab logoPortfoliosLab logo
DADA vs. NVAX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DADA vs. NVAX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Dada Nexus Limited (DADA) and Novavax, Inc. (NVAX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


DADA

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

NVAX

1D
-2.85%
1M
26.99%
YTD
51.93%
6M
54.70%
1Y
44.41%
3Y*
10.24%
5Y*
-43.27%
10Y*
-21.99%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DADA vs. NVAX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
DADA
Dada Nexus Limited
0.00%61.98%-63.55%-52.37%-47.04%-63.95%128.27%
NVAX
Novavax, Inc.
51.93%-16.42%67.50%-53.31%-92.81%28.30%140.84%

Correlation

The correlation between DADA and NVAX is -0.02, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.02

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Jun 8, 2020

0.28

The correlation between DADA and NVAX shifts across timeframes, from -0.02 (1 year) to 0.29 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Total Revenue (TTM)

DADA:

$9.66B

NVAX:

$596.34M

Gross Profit (TTM)

DADA:

$2.44B

NVAX:

$504.72M

EBITDA (TTM)

DADA:

-$743.79M

NVAX:

-$57.01M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DADA vs. NVAX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DADA

NVAX
NVAX Risk / Return Rank: 6161
Overall Rank
NVAX Sharpe Ratio Rank: 6161
Sharpe Ratio Rank
NVAX Sortino Ratio Rank: 6464
Sortino Ratio Rank
NVAX Omega Ratio Rank: 5959
Omega Ratio Rank
NVAX Calmar Ratio Rank: 6262
Calmar Ratio Rank
NVAX Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DADA vs. NVAX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Dada Nexus Limited (DADA) and Novavax, Inc. (NVAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

DADA vs. NVAX - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


DADANVAXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.65

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.41

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.07

Drawdowns

DADA vs. NVAX - Drawdown Comparison


Loading charts...

Drawdown Indicators


DADANVAXDifference

Max Drawdown

Largest peak-to-trough decline

-98.82%

Max Drawdown (1Y)

Largest decline over 1 year

-35.94%

Max Drawdown (3Y)

Largest decline over 3 years

-74.11%

Max Drawdown (5Y)

Largest decline over 5 years

-98.61%

Max Drawdown (10Y)

Largest decline over 10 years

-98.82%

Current Drawdown

Current decline from peak

-96.81%

Average Drawdown

Average peak-to-trough decline

-70.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

18.37%

Volatility

DADA vs. NVAX - Volatility Comparison


Loading charts...

Volatility by Period


DADANVAXDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.80%

Volatility (6M)

Calculated over the trailing 6-month period

50.99%

Volatility (1Y)

Calculated over the trailing 1-year period

68.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

106.06%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

115.49%

Dividends

DADA vs. NVAX - Dividend Comparison

Neither DADA nor NVAX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DADA vs. NVAX - Financials Comparison

This section allows you to compare key financial metrics between Dada Nexus Limited and Novavax, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-1.00B0.001.00B2.00B3.00B20222023202420252026
2.43B
139.51M
(DADA) Total Revenue
(NVAX) Total Revenue
Values in USD except per share items

Frequently Asked Questions


DADA and NVAX have a correlation of -0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for DADA and NVAX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer